Novel SARS-CoV-2 Variant in Travelers from Brazil to Japan

doi:10.3201/eid2704.210138

Case Reports

. 2021 Apr;27(4):1243-1245.

doi: 10.3201/eid2704.210138. Epub 2021 Feb 10.

Novel SARS-CoV-2 Variant in Travelers from Brazil to Japan

Takahisa Fujino, Hidetoshi Nomoto, Satoshi Kutsuna, Mugen Ujiie, Tetsuya Suzuki, Rubuna Sato, Tsuguto Fujimoto, Makoto Kuroda, Takaji Wakita, Norio Ohmagari

PMID: 33567247
PMCID: PMC8007308
DOI: 10.3201/eid2704.210138

Case Reports

Novel SARS-CoV-2 Variant in Travelers from Brazil to Japan

Takahisa Fujino et al. Emerg Infect Dis. 2021 Apr.

. 2021 Apr;27(4):1243-1245.

doi: 10.3201/eid2704.210138. Epub 2021 Feb 10.

Authors

Takahisa Fujino, Hidetoshi Nomoto, Satoshi Kutsuna, Mugen Ujiie, Tetsuya Suzuki, Rubuna Sato, Tsuguto Fujimoto, Makoto Kuroda, Takaji Wakita, Norio Ohmagari

PMID: 33567247
PMCID: PMC8007308
DOI: 10.3201/eid2704.210138

Abstract

Multiple severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants with higher transmission potential have been emerging globally, including SARS-CoV-2 variants from the United Kingdom and South Africa. We report 4 travelers from Brazil to Japan in January 2021 infected with a novel SARS-CoV-2 variant with an additional set of mutations.

Keywords: Brazil; COVID-19; Japan; SARS; SARS-CoV-2; coronavirus; coronavirus disease; respiratory infections; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses.

PubMed Disclaimer

Cited by

An Updated Review of SARS-CoV-2 Vaccines and the Importance of Effective Vaccination Programs in Pandemic Times.
García-Montero C, Fraile-Martínez O, Bravo C, Torres-Carranza D, Sanchez-Trujillo L, Gómez-Lahoz AM, Guijarro LG, García-Honduvilla N, Asúnsolo A, Bujan J, Monserrat J, Serrano E, Álvarez-Mon M, De León-Luis JA, Álvarez-Mon MA, Ortega MA. García-Montero C, et al. Vaccines (Basel). 2021 Apr 27;9(5):433. doi: 10.3390/vaccines9050433. Vaccines (Basel). 2021. PMID: 33925526 Free PMC article. Review.
The role of N-glycosylation in spike antigenicity for the SARS-CoV-2 gamma variant.
Pegg CL, Modhiran N, Parry RH, Liang B, Amarilla AA, Khromykh AA, Burr L, Young PR, Chappell K, Schulz BL, Watterson D. Pegg CL, et al. Glycobiology. 2024 Mar 26;34(2):cwad097. doi: 10.1093/glycob/cwad097. Glycobiology. 2024. PMID: 38048640 Free PMC article.
Fractionation of sulfated galactan from the red alga Botryocladia occidentalis separates its anticoagulant and anti-SARS-CoV-2 properties.
Kim SB, Zoepfl M, Samanta P, Zhang F, Xia K, Thara R, Linhardt RJ, Doerksen RJ, McVoy MA, Pomin VH. Kim SB, et al. J Biol Chem. 2022 May;298(5):101856. doi: 10.1016/j.jbc.2022.101856. Epub 2022 Mar 23. J Biol Chem. 2022. PMID: 35337800 Free PMC article.
Genomic Epidemiology of SARS-CoV-2 in Tocantins State and the Diffusion of P.1.7 and AY.99.2 Lineages in Brazil.
de Souza UJB, Dos Santos RN, de Melo FL, Belmok A, Galvão JD, de Rezende TCV, Cardoso FDP, Carvalho RF, da Silva Oliveira M, Ribeiro Junior JC, Gabev EE, Sabino EC, Arns CW, Ribeiro BM, Spilki FR, Campos FS. de Souza UJB, et al. Viruses. 2022 Mar 23;14(4):659. doi: 10.3390/v14040659. Viruses. 2022. PMID: 35458389 Free PMC article.
Genomic epidemiology of SARS- CoV-2 Omicron variants in the Republic of Korea.
Lee DW, Kim JM, Park AK, Kim DW, Kim JY, Lim N, Lee H, Kim IH, Kim JA, Lee CY, Kwon JH, Kim EJ. Lee DW, et al. Sci Rep. 2022 Dec 27;12(1):22414. doi: 10.1038/s41598-022-26803-w. Sci Rep. 2022. PMID: 36575217 Free PMC article.

See all "Cited by" articles

References

1. World Health Organization. Coronavirus disease (COVID-19) situation reports. Weekly epidemiological update—19 January 2021. [cited 2021 Jan 21]. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situatio...
1. World Health Organization. SARS-CoV-2 variant [cited 2021 Jan 21]. https://www.who.int/csr/don/31-december-2020-sars-cov2-variants/en/
1. European Centre for Disease Prevention and Control. Rapid increase of a SARS-CoV-2 variant with multiple spike protein mutations observed in the United Kingdom; December 20, 2020. [cited 2021 Jan 21]. https://www.ecdc.europa.eu/sites/default/files/documents/SARS-CoV-2-vari...
1. The New and Emerging Respiratory Virus Threats Advisory Group (NERVTAG). NERVTAG meeting on SARS-CoV-2 variant under investigation VUI-202012/01. 2020. Dec 18 [cited 2021 Jan 21]. https://app.box.com/s/3lkcbxepqixkg4mv640dpvvg978ixjtf/file/756963730457
1. New and Emerging Respiratory Virus Threats Advisory Group. NERVTAG/SPI-M Extraordinary meeting on SARS-CoV-2 variant of concern 202012/01 (variant B.1.1.7). Note of meeting 2020. Dec 21 [cited 2021 Jan 21]. https://app.box.com/s/3lkcbxepqixkg4mv640dpvvg978ixjtf/file/756964987830

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Miscellaneous
- NCI CPTAC Assay Portal

[1] World Health Organization. Coronavirus disease (COVID-19) situation reports. Weekly epidemiological update—19 January 2021. [cited 2021 Jan 21]. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situatio...

[2] World Health Organization. Coronavirus disease (COVID-19) situation reports. Weekly epidemiological update—19 January 2021. [cited 2021 Jan 21]. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situatio...

[3] World Health Organization. SARS-CoV-2 variant [cited 2021 Jan 21]. https://www.who.int/csr/don/31-december-2020-sars-cov2-variants/en/

[4] World Health Organization. SARS-CoV-2 variant [cited 2021 Jan 21]. https://www.who.int/csr/don/31-december-2020-sars-cov2-variants/en/

[5] European Centre for Disease Prevention and Control. Rapid increase of a SARS-CoV-2 variant with multiple spike protein mutations observed in the United Kingdom; December 20, 2020. [cited 2021 Jan 21]. https://www.ecdc.europa.eu/sites/default/files/documents/SARS-CoV-2-vari...

[6] European Centre for Disease Prevention and Control. Rapid increase of a SARS-CoV-2 variant with multiple spike protein mutations observed in the United Kingdom; December 20, 2020. [cited 2021 Jan 21]. https://www.ecdc.europa.eu/sites/default/files/documents/SARS-CoV-2-vari...

[7] The New and Emerging Respiratory Virus Threats Advisory Group (NERVTAG). NERVTAG meeting on SARS-CoV-2 variant under investigation VUI-202012/01. 2020. Dec 18 [cited 2021 Jan 21]. https://app.box.com/s/3lkcbxepqixkg4mv640dpvvg978ixjtf/file/756963730457

[8] The New and Emerging Respiratory Virus Threats Advisory Group (NERVTAG). NERVTAG meeting on SARS-CoV-2 variant under investigation VUI-202012/01. 2020. Dec 18 [cited 2021 Jan 21]. https://app.box.com/s/3lkcbxepqixkg4mv640dpvvg978ixjtf/file/756963730457

[9] New and Emerging Respiratory Virus Threats Advisory Group. NERVTAG/SPI-M Extraordinary meeting on SARS-CoV-2 variant of concern 202012/01 (variant B.1.1.7). Note of meeting 2020. Dec 21 [cited 2021 Jan 21]. https://app.box.com/s/3lkcbxepqixkg4mv640dpvvg978ixjtf/file/756964987830

[10] New and Emerging Respiratory Virus Threats Advisory Group. NERVTAG/SPI-M Extraordinary meeting on SARS-CoV-2 variant of concern 202012/01 (variant B.1.1.7). Note of meeting 2020. Dec 21 [cited 2021 Jan 21]. https://app.box.com/s/3lkcbxepqixkg4mv640dpvvg978ixjtf/file/756964987830

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Novel SARS-CoV-2 Variant in Travelers from Brazil to Japan

Novel SARS-CoV-2 Variant in Travelers from Brazil to Japan

Authors

Abstract

Similar articles

Cited by

References

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

Miscellaneous

Abstract

Similar articles

Cited by

References

Publication types

MeSH terms

Related information

LinkOut - more resources

Full Text Sources

Other Literature Sources

Miscellaneous